A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2, PHASE3

מצבים רפואיים

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Ruane Clinical Research Group, Inc. ( Site 1513), Los Angeles, California, United States

    Study coordinator · 323-954-0400
  • Vivent Health ( Site 1519), Denver, Colorado, United States

    Study coordinator · 303-393-8050
  • Whitman-Walker Institute ( Site 1538), Washington D.C., District of Columbia, United States

    Study coordinator · 202-207-2510
  • Midway Immunology and Research Center ( Site 1503), Ft. Pierce, Florida, United States

    Study coordinator · 772-595-9830
  • CAN Community Health- Miami Gardens ( Site 1549), Miami Gardens, Florida, United States

    Study coordinator · 954-955-0023
  • Orlando Immunology Center ( Site 1501), Orlando, Florida, United States

    Study coordinator · 407-374-0220
  • CAN Community Health ( Site 1510), Sarasota, Florida, United States

    Study coordinator · 941-366-0134
  • Triple O Research Institute ( Site 1505), West Palm Beach, Florida, United States

    Study coordinator · 561-855-7871
  • Metro Infectious Diseases Consultants L.L.C. ( Site 1509), Decatur, Georgia, United States

    Study coordinator · 404-297-9755
  • Mercer university, Department of internal medicine-Clinical Research ( Site 1512), Macon, Georgia, United States

    Study coordinator · 478-301-5846
  • Rush University Medical Center-Infectious Disease ( Site 1522), Chicago, Illinois, United States

    Study coordinator · 312-942-5865
  • Henry Ford Hospital ( Site 1535), Detroit, Michigan, United States

    Study coordinator · 313-916-2600
  • KC CARE Health Center ( Site 1506), Kansas City, Missouri, United States

    Study coordinator · 816-753-5144
  • ID Care ( Site 1507), Hillsborough, New Jersey, United States

    Study coordinator · 908-281-0221
  • Atrium Health Infectious Disease Kenilworth - Charlotte ( Site 1533), Charlotte, North Carolina, United States

    Study coordinator · 704-468-3510
  • Regional Center for Infectious Diseases ( Site 1516), Greensboro, North Carolina, United States

    Study coordinator · 336-832-3275
  • The Ohio State University ( Site 1536), Columbus, Ohio, United States

    Study coordinator · 614-293-8112
  • University of Pennsylvania Perelman School of Medicine ( Site 1508), Philadelphia, Pennsylvania, United States

    Study coordinator · 215-349-8092
  • Saint Hope Foundation, Inc. ( Site 1504), Bellaire, Texas, United States

    Study coordinator · 713-839-7111
  • Prism Health North Texas, Oak Cliff Health Center ( Site 1514), Dallas, Texas, United States

    Study coordinator · 214-521-5191
  • North Texas Infectious Diseases Consultants ( Site 1500), Dallas, Texas, United States

    Study coordinator · 214-276-5627
  • Texas Center for Infectious Disease Associates ( Site 1502), Fort Worth, Texas, United States

    Study coordinator · 817-348-0042
  • DCOL Center for Clinical Research ( Site 1511), Longview, Texas, United States

    Study coordinator · 903-238-8854
  • Harborview Medical Center ( Site 1526), Seattle, Washington, United States

    Study coordinator · 206-744-8886
  • Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada ( Site 3102), Caba, Buenos Aires, Argentina

    Study coordinator · +5491141639539
  • Fundación Huesped ( Site 3100), CABA, Buenos Aires, Argentina

    Study coordinator · +541121209999
  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 3103), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +5492234365218
  • Fundación IDEAA ( Site 3101), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +5491161835390
  • Instituto CAICI SRL ( Site 3106), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543414248045
  • Clínica Mayo de Urgencias Médicas Cruz Blanca S.R.L ( Site 3105), San Miguel de Tucumán, Tucumán Province, Argentina

    Study coordinator · +5403814502600
  • Spectrum Health ( Site 3307), Vancouver, British Columbia, Canada

    Study coordinator · 6046853747
  • Gestion clinique médicale l'Actuel ( Site 3303), Montreal, Quebec, Canada

    Study coordinator · 5145243642x2271
  • Biomedica Research Group ( Site 4201), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56222045686
  • Clínica Universidad de Los Andes ( Site 4207), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56226183123
  • Espacio Eme ( Site 4202), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56990008060
  • Bordeaux University Hospital - Pellegrin ( Site 3605), Bordeaux, Gironde, France

    Study coordinator · +33556795536
  • Centre Hospitalier Universitaire de Toulouse - Hôpital Purpan ( Site 3608), Toulouse, Haute-Garonne, France

    Study coordinator · +33561776800
  • Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu-Infectious Disease ( Site 3606), Nantes, Pays de la Loire Region, France

    Study coordinator · +33240083109
  • HOPITAL DE LA CROIX ROUSSE ( Site 3613), Lyon, Rhone, France

    Study coordinator · +33472071107
  • Hôpital Avicenne ( Site 3602), Bobigny, Île-de-France Region, France

    Study coordinator · +33148955421
  • Hôpital Saint-Louis ( Site 3600), Paris, Île-de-France Region, France

    Study coordinator · +33142494852
  • Hôpital Bichat - Claude-Bernard ( Site 3601), Paris, Île-de-France Region, France

    Study coordinator · +33140257803
  • Clínica Médica Especializada en Pediatría e Infectología Pediátrica - Dr. Mario Melgar ( Site 3801), Guatemala City, Guatemala

    Study coordinator · +50223196600
  • MEDI-K ( Site 3803), Guatemala City, Guatemala

    Study coordinator · +50222912323
  • CELAN,S.A ( Site 3802), Guatemala City, Guatemala

    Study coordinator · +50222968018
  • Morales Vargas Centro de Investigacion, S.C. ( Site 4502), León, Guanajuato, Mexico

    Study coordinator · 4777160714
  • Josha Research ( Site 4302), Bloemfontein, Free State, South Africa

    Study coordinator · +27 51 412 8160
  • Wentworth Hospital ( Site 4303), Durban, KwaZulu-Natal, South Africa

    Study coordinator · +27837471149
  • Be Part Yoluntu Centre ( Site 4300), Mbekweni, Paarl, Western Cape, South Africa

    Study coordinator · +27 21 8683990/1/2
  • Hospital Universitario La Paz ( Site 3404), Madrid, Madrid, Comunidad de, Spain

    Study coordinator · +34915383515
  • Consorcio Hospital General Universitario de Valencia ( Site 3406), Valencia, Valenciana, Comunitat, Spain

    Study coordinator · +34 963131800x437834
  • Hospital Universitari Vall d'Hebron ( Site 3402), Barcelona, Spain

    Study coordinator · +34934894377
  • HOSPITAL CLÍNIC DE BARCELONA ( Site 3400), Barcelona, Spain

    Study coordinator · +34932275574
  • Hospital Universitario 12 de Octubre ( Site 3405), Madrid, Spain

    Study coordinator · +34917792853
  • Complejo Hospitalario Virgen De La Victoria ( Site 3409), Málaga, Spain

    Study coordinator · +34 951032594
מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC